Ccetylcholinesterase inhibitors (AChEIs) used to treat Alzheimer’s disease may lower the risk for developing age-related macular degeneration (AMD), according to a study published last week in JAMA Ophthalmology. During the study, the researchers evaluated 12,487 VA patients with Alzheimer’s diagnoses who were on AChEIs and 4,898 people who took an alternative dementia drug Namenda (memantine). […]
